We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

162 hedge funds and large institutions have $296M invested in Niagen Bioscience in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 38 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $1.03M

79% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 38

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

5% more funds holding

Funds holding: 155 → 162 (+7)

2.97% more ownership

Funds ownership: 36.84% → 39.8% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

29% less capital invested

Capital invested by funds: $418M → $296M (-$122M)

Holders
162
Holders Change
+7
Holders Change %
+4.52%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
68
Reduced
38
Closed
24
Calls
$1.9M
Puts
$1.03M
Net Calls
+$869K
Net Calls Change
+$546K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$11.2M
2
Millennium Management
Millennium Management
New York
+$6.59M
3
AG
Algert Global
California
+$4.51M
4
Charles Schwab
Charles Schwab
California
+$4.19M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.87M

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$10.7M
2
WCM
Woodson Capital Management
Connecticut
-$7.21M
3
Invesco
Invesco
Georgia
-$4.37M
4
JF
Jump Financial
Illinois
-$3.44M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
101
Arax Advisory Partners
Colorado
$188K +$203K +20,145 New
Mariner
102
Mariner
Kansas
$180K +$2.52K +250 +1%
Osaic Holdings
103
Osaic Holdings
Arizona
$173K +$109K +10,768 +158%
Fidelity Investments
104
Fidelity Investments
Massachusetts
$172K +$7.74K +767 +4%
Manulife (Manufacturers Life Insurance)
105
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$167K -$15K -1,485 -8%
Zurich Cantonal Bank
106
Zurich Cantonal Bank
Switzerland
$165K +$179K +17,700 New
Cetera Investment Advisers
107
Cetera Investment Advisers
Illinois
$162K +$176K +17,409 New
New York State Common Retirement Fund
108
New York State Common Retirement Fund
New York
$157K – – –
GAM
109
Gotham Asset Management
New York
$155K +$168K +16,665 New
ASRS
110
Arizona State Retirement System
Arizona
$152K +$165K +16,299 New
Man Group
111
Man Group
United Kingdom
$148K +$160K +15,866 New
Allspring Global Investments
112
Allspring Global Investments
North Carolina
$144K -$1.54K -153 -1%
SCA
113
Snowden Capital Advisors
New York
$140K – – –
AI
114
Atom Investors
Texas
$137K +$148K +14,641 New
PFSRSONJ
115
Police & Firemen's Retirement System of New Jersey
New Jersey
$135K +$32.1K +3,182 +28%
Jones Financial Companies
116
Jones Financial Companies
Missouri
$134K -$113K -11,237 -45%
AIM
117
Aigen Investment Management
New York
$118K +$128K +12,669 New
OAC
118
OMERS Administration Corp
Ontario, Canada
$107K +$5.05K +500 +5%
KK
119
KLP Kapitalforvaltning
Norway
$107K +$116K +11,500 New
BCM
120
Bayesian Capital Management
New York
$104K -$33.3K -3,300 -23%
MCM
121
MAI Capital Management
Ohio
$99.5K – – –
Wealth Enhancement Advisory Services
122
Wealth Enhancement Advisory Services
Minnesota
$96.7K +$636 +63 +0.5%
BHCM
123
Brevan Howard Capital Management
Jersey
$96K +$104K +10,291 New
BNP Paribas Financial Markets
124
BNP Paribas Financial Markets
France
$95.9K -$750K -74,294 -88%
PCM
125
Polymer Capital Management
New York
$95.5K +$103K +10,241 New
3 4
5
6 7

NAGE Hedge Fund Activity: Q3 2025 in Review

162 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2025, worth a combined $296M — down 29% from $418M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NAGE positions and 24 closed out — a net gain of 8 holders — while 68 added to existing stakes and 38 trimmed.

The largest buyer was UBS Group, adding an estimated $11.2M. The largest seller was D.E. Shaw & Co, cutting an estimated $10.7M.

  • 162 institutional investors held Niagen Bioscience (NAGE) as of Q3 2025, up from 155 in Q2 2025.
  • Funds reported $296M of Niagen Bioscience stock for Q3 2025, down 29% quarter-over-quarter.
  • 32 funds opened new Niagen Bioscience positions in Q3 2025 and 24 closed out, a net change of +8 holders.
  • The largest Niagen Bioscience buyer in Q3 2025 was UBS Group, an estimated $11.2M added.
  • The largest Niagen Bioscience seller in Q3 2025 was D.E. Shaw & Co, an estimated $10.7M sold.

Based on aggregated 13F filings for Q3 2025.